Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAZZANIGA, G")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2
Export

Selection :

  • and

Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patientsBARDINI, M; GALBIATI, M; LETTIERI, A et al.Leukemia. 2011, Vol 25, Num 1, pp 175-178, issn 0887-6924, 4 p.Article

Low prevalence of IDH1 gene mutation in childhood AML in ItalyPIGAZZI, M; FERRARI, G; MASETTI, R et al.Leukemia. 2011, Vol 25, Num 1, pp 173-174, issn 0887-6924, 2 p.Article

Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia : correlation with specific genotype. I. ETV6/AML1 ALLs identificationDE ZEN, L; ORFAO, A; CAZZANIGA, G et al.Leukemia. 2000, Vol 14, Num 7, pp 1225-1231, issn 0887-6924Article

Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosisLO NIGRO, L; CAZZANIGA, G; DI CATALDO, A et al.Leukemia. 1999, Vol 13, Num 2, pp 190-195, issn 0887-6924Article

Chromosomal mapping, isolation, and characterization of the mouse xanthine dehydrogenase geneCAZZANIGA, G; TERAO, M; LO SCHIAVO, P et al.Genomics (San Diego, Calif.). 1994, Vol 23, Num 2, pp 390-402, issn 0888-7543Article

Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase : regulation of its transcript by interferons in vivoTERAO, M; CAZZANIGA, G; GHEZZI, P et al.Biochemical journal (London. 1984). 1992, Vol 283, pp 863-870, issn 0264-6021, 3Article

Il lavoro: problemi di teoria. (Le travail: problèmes de théorie)BADALONI, A; CAZZANIGA, G. M; GRUPPI, L et al.Critica Marxista Roma. 1984, Vol 22, Num 6, pp 5-63Article

Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays : towards new standards for gene expression measurementsSALDANHAL, J; SILVY, M; KAIRISTO, V et al.Leukemia. 2007, Vol 21, Num 7, pp 1481-1487, issn 0887-6924, 7 p.Article

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsVAN DER VELDEN, V. H. J; HOCHHAUS, A; CAZZANIGA, G et al.Leukemia. 2003, Vol 17, Num 6, pp 1013-1034, issn 0887-6924, 22 p.Article

Comparison between Taqman and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probesECKERT, C; SCRIDELI, C. A; TAUBE, T et al.Leukemia. 2003, Vol 17, Num 12, pp 2517-2524, issn 0887-6924, 8 p.Article

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodVAN DONGEN, J. J. M; SERIU, T; GADNER, H et al.Lancet (British edition). 1998, Vol 352, Num 9142, pp 1731-1738, issn 0140-6736Article

Molybdenum(VI) salts convert the xanthine oxidoreductase apoprotein into the active enzyme in mouse L929 fibroblastic cellsFALCIANI, F; TERAO, M; GOLDWURM, S et al.Biochemical journal (London. 1984). 1994, Vol 298, pp 69-77, issn 0264-6021, 1Article

Interferons induce xanthine dehydrogenase gene expression in L929 cellsFALCIANI, F; GHEZZI, P; TERAO, M et al.Biochemical journal (London. 1984). 1992, Vol 285, pp 1001-1008, issn 0264-6021, 3Article

Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemiaELLINGHAUS, E; STANULLA, M; TRKA, J et al.Leukemia. 2012, Vol 26, Num 5, pp 902-909, issn 0887-6924, 8 p.Article

The effect of nano-scale interaction forces on the premature pull-in of real-life Micro-Electro-Mechanical SystemsARDITO, R; FRANGI, A; CORIGLIANO, A et al.Microelectronics and reliability. 2012, Vol 52, Num 1, pp 271-281, issn 0026-2714, 11 p.Article

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidyMOLTENI, C. G; TE KRONNIE, G; BICCIATO, S et al.Leukemia. 2010, Vol 24, Num 1, pp 232-235, issn 0887-6924, 4 p.Article

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocolVAN DER VELDEN, Vhj; CORRAL, L; MARSCHALEK, R et al.Leukemia. 2009, Vol 23, Num 6, pp 1073-1079, issn 0887-6924, 7 p.Article

Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter studyWILLASCH, A. M; GRUHN, B; BIONDI, A et al.Leukemia. 2009, Vol 23, Num 8, pp 1472-1479, issn 0887-6924, 8 p.Article

Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksSTAAL, F. J. T; CARIO, G; VAN DONGEN, J. J. M et al.Leukemia. 2006, Vol 20, Num 8, pp 1385-1392, issn 0887-6924, 8 p.Article

High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasHÜBNER, S; CAZZANIGA, G; BIONDI, A et al.Leukemia. 2004, Vol 18, Num 1, pp 84-91, issn 0887-6924, 8 p.Article

Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoringGERMANO, G; DEL GIUDICE, L; PALATRON, S et al.Leukemia. 2003, Vol 17, Num 8, pp 1573-1582, issn 0887-6924, 10 p.Article

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaFLOHR, T; SCHRAUDER, A; SUTTON, R et al.Leukemia. 2008, Vol 22, Num 4, pp 771-782, issn 0887-6924, 12 p.Article

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingVAN DER VELDEN, V. H. J; PANZER-GRÜMAYER, E. R; BARTRAM, C. R et al.Leukemia. 2007, Vol 21, Num 4, pp 706-713, issn 0887-6924, 8 p.Article

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionGAIPA, G; BASSO, G; COLIVA, T et al.Leukemia. 2005, Vol 19, Num 1, pp 49-56, issn 0887-6924, 8 p.Article

Rituximab for immune hemolytic anemia following T- and B-cell-depleted hematopoietic stem cell transplantationCORTI, P; BONANOMI, S; VALLINOTO, C et al.Acta haematologica. 2003, Vol 109, Num 1, pp 43-45, issn 0001-5792, 3 p.Article

  • Page / 2